ブラキセラピー (小線源療法) の世界市場：製品タイプ (高線量率・低線量率)・技術・適応症・エンドユーザー・地域別の予測 (～2032年)

世界のブラキセラピー (小線源療法) の市場規模は、2023年の9億8,000万米ドル、2024年の10億7,000万米ドルから、予測期間中は6.84％のCAGRで推移し、2032年には19億4,000万米ドルの規模に成長すると予測されています。

癌患者により多くの治療選択肢を与えることから、ブラキセラピーの導入はブラキセラピー市場の成長を大きく加速させています。従来の放射線療法に代わる効率的な治療法を求める患者が増え、医療施設はこの集中的で低侵襲な技術を取り入れるよう提案の幅を広げています。ブラキセラピーは、健康な組織を保護しながら悪性腫瘍に焦点を絞った放射線量を直接照射することで、患者の予後と満足度を向上させています。

さらに、治療期間が短縮され、副作用が少なくなることから、患者やヘルスケアプロバイダーの受け入れも進んでいます。子宮頸癌と食道癌の治療における重要な展開は、2024年9月にインドのKarnataka Medical College and Research Instituteがブラキセラピーを導入したことです。

地域別展望

北米地域が2023年に最大の市場シェアを占めています。また、予測期間中はアジア太平洋が7.98%のCAGRで最大の成長を示すと予測されています。

北米市場の成長は癌治療戦略の大きな進展を示しています。特に子宮頸癌、乳癌、前立腺癌などの限局型癌が増加するにつれて、効率的な治療に対するニーズが高まっています。

アジア太平洋地市場は、さまざまな要因が絡み合って急速に拡大しています。癌、特に乳癌、前立腺癌、子宮頸癌の罹患率の顕著な上昇により、効率的な代替治療へのニーズが高まっています。

当レポートでは、世界のブラキセラピー (小線源療法) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 促進要因
  • ブラキセラピーの導入
  • 世界で癌の発生率が増加
  • 製品発売数の増加
  • 医療従事者と患者の間でのブラキセラピーの利点に関する認識の高まり
• 抑制要因
  • ブラキセラピーの高額な費用
  • 代替癌治療法との競合
• 機会
  • ブラキセラピーの適用範囲の拡大
  • ブラキセラピーに関連する技術的進歩
  • ブラキセラピー製造施設と製品ポートフォリオの拡大

第5章 市場要因分析

• ポーターのファイブフォース分析
• COVID-19が世界のブラキセラピー市場に与える影響

第6章 世界のブラキセラピー市場：製品別

• 概要
• アフターローダー・アプリケーター
• 放射性種子
• 電子ブラキセラピー
• イメージングシステム
• その他

第7章 世界のブラキセラピー市場：タイプ別

• 概要
• 高線量率 (HDR) ブラキセラピー
• 低線量率 (LDR) ブラキセラピー

第8章 世界のブラキセラピー市場：技術別

• 概要
• 組織内ブラキセラピー
• 腔内ブラキセラピー

第9章 世界のブラキセラピー市場：適応症別

• 概要
• 前立腺癌
• 乳癌
• 子宮頸癌
• 皮膚癌
• その他

第10章 世界のブラキセラピー市場：エンドユーザー別

• 概要
• 病院・専門クリニック
• 癌治療センター
• その他

第11章 世界のブラキセラピー市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他
• その他の地域
  • 中東
  • アフリカ
  • 南米

第12章 競合情勢

• 市場シェア分析
• 競合ダッシュボード
• 公開企業の株式概要
• 比較分析：主要企業の財務動向
• 主な展開・成長戦略

第13章 企業プロファイル

• ELEKTA
• BEBIG MEDICAL GMBH
• THERAGENICS CORPORATION
• SIEMENS HEALTHINEERS AG
• ECKERT & ZIEGLER
• BECTON, DICKINSON AND COMPANY
• GE HEALTHCARE
• MERIT MEDICAL SYSTEMS
• BEST MEDICAL INTERNATIONAL, INC.
• ISOAID, LLC

第14章 データの引用

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 PROSTATE CANCER INCIDENCE, BY COUNTRY,
• TABLE 3 BREAST CANCER INCIDENCE, BY COUNTRY,
• TABLE 4 CERVICAL CANCER INCIDENCE, BY COUNTRY,
• TABLE 5 COST OF THE BRACHYTHERAPY BASED ON THE TYPE OF CANCER / CONDITIONS IN VARIOUS COUNTRIES (IN USD)
• TABLE 6 GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 7 GLOBAL BRACHYTHERAPY MARKET, FOR AFTERLOADERS & APPLICATORS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 8 GLOBAL BRACHYTHERAPY MARKET, FOR RADIOACTIVE SEEDS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 9 GLOBAL BRACHYTHERAPY MARKET, FOR ELECTRONIC BRACHYTHERAPY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 10 GLOBAL BRACHYTHERAPY MARKET, FOR IMAGING SYSTEMS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 11 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 12 GLOBAL BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 13 GLOBAL BRACHYTHERAPY MARKET, FOR HIGH DOSE-RATE (HDR) BRACHYTHERAPY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 14 GLOBAL BRACHYTHERAPY MARKET, FOR LOW DOSE-RATE (LDR) BRACHYTHERAPY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 15 GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 16 GLOBAL BRACHYTHERAPY MARKET, FOR INTERSTITIAL BRACHYTHERAPY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 17 GLOBAL BRACHYTHERAPY MARKET, FOR INTRACAVITARY BRACHYTHERAPY, BY REGION, 2019-2032 (USD BILLION)
• TABLE 18 GLOBAL BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 19 GLOBAL BRACHYTHERAPY MARKET, FOR PROSTRATE CANCER, BY REGION, 2019-2032 (USD BILLION)
• TABLE 20 GLOBAL BRACHYTHERAPY MARKET, FOR BREAST CANCER, BY REGION, 2019-2032 (USD BILLION)
• TABLE 21 GLOBAL BRACHYTHERAPY MARKET, FOR CERVICAL CANCER, BY REGION, 2019-2032 (USD BILLION)
• TABLE 22 GLOBAL BRACHYTHERAPY MARKET, FOR SKIN CANCER, BY REGION, 2019-2032 (USD BILLION)
• TABLE 23 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 24 GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 25 GLOBAL BRACHYTHERAPY MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 26 GLOBAL BRACHYTHERAPY MARKET, FOR CANCER TREATMENT CENTERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 27 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
• TABLE 28 GLOBAL BRACHYTHERAPY MARKET, BY REGION, 2019-2032 (USD BILLION)
• TABLE 29 NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 30 NORTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 31 NORTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 32 NORTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 33 NORTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 34 NORTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 35 US: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 36 US: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 37 US: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 38 US: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 39 US: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 40 CANADA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 41 CANADA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 42 CANADA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 43 CANADA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 44 CANADA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 45 MEXICO: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 46 MEXICO: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 47 MEXICO: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 48 MEXICO: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 49 MEXICO: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 50 EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 51 EUROPE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 52 EUROPE: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 53 EUROPE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 54 EUROPE: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 55 EUROPE: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 56 GERMANY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 57 GERMANY: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 58 GERMANY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 59 GERMANY: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 60 GERMANY: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 61 FRANCE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 62 FRANCE: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 63 FRANCE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 64 FRANCE: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 65 FRANCE: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 66 UK: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 67 UK: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 68 UK: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 69 UK: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 70 UK: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 71 ITALY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 72 ITALY: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 73 ITALY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 74 ITALY: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 75 ITALY: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 76 SPAIN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 77 SPAIN: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 78 SPAIN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 79 SPAIN: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 80 SPAIN: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 81 REST OF EUROPE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 82 REST OF EUROPE: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 83 REST OF EUROPE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 84 REST OF EUROPE: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 85 REST OF EUROPE: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 86 ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 87 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 88 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 89 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 90 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 91 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 92 CHINA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 93 CHINA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 94 CHINA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 95 CHINA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 96 CHINA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 97 INDIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 98 INDIA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 99 INDIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 100 INDIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 101 INDIA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 102 JAPAN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 103 JAPAN: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 104 JAPAN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 105 JAPAN: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 106 JAPAN: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 107 SOUTH KOREA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 108 SOUTH KOREA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 109 SOUTH KOREA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 110 SOUTH KOREA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 111 SOUTH KOREA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 112 AUSTRALIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 113 AUSTRALIA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 114 AUSTRALIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 115 AUSTRALIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 116 AUSTRALIA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 117 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 118 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 119 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 120 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 121 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 122 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 123 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 124 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 125 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 126 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 127 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 128 MIDDLE EAST: BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 129 MIDDLE EAST: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 130 MIDDLE EAST: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 131 MIDDLE EAST: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 132 MIDDLE EAST: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 133 MIDDLE EAST: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 134 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 135 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 136 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 137 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 138 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 139 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 140 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 141 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 142 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 143 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 144 OMAN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 145 OMAN: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 146 OMAN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 147 OMAN: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 148 OMAN: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 149 QATAR: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 150 QATAR: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 151 QATAR: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 152 QATAR: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 153 QATAR: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 154 TURKEY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 155 TURKEY: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 156 TURKEY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 157 TURKEY: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 158 TURKEY: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 159 KUWAIT: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 160 KUWAIT: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 161 KUWAIT: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 162 KUWAIT: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 163 KUWAIT: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 164 BAHRAIN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 165 BAHRAIN: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 166 BAHRAIN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 167 BAHRAIN: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 168 BAHRAIN: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 169 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 170 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 171 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 172 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 173 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 174 AFRICA: BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 175 AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 176 AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 177 AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 178 AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 179 AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 180 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 181 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 182 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 183 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 184 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 185 MOROCCO: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 186 MOROCCO: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 187 MOROCCO: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 188 MOROCCO: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 189 MOROCCO: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 190 REST OF AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 191 REST OF AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 192 REST OF AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 193 REST OF AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 194 REST OF AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 195 AFRICA: BRACHYTHERAPY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
• TABLE 196 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 197 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 198 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 199 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 200 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 201 BRAZIL: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 202 BRAZIL: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 203 BRAZIL: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 204 BRAZIL: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 205 BRAZIL: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 206 ARGENTINA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 207 ARGENTINA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 208 ARGENTINA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 209 ARGENTINA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 210 ARGENTINA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 211 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
• TABLE 212 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019-2032 (USD BILLION)
• TABLE 213 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019-2032 (USD BILLION)
• TABLE 214 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019-2032 (USD BILLION)
• TABLE 215 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019-2032 (USD BILLION)
• TABLE 216 PUBLIC PLAYERS STOCK SUMMARY
• TABLE 217 PRODUCT LAUNCH
• TABLE 218 PRODUCT APPROVAL
• TABLE 219 ACQUISITION
• TABLE 220 ELEKTA: PRODUCTS OFFERED
• TABLE 221 ELEKTA: KEY DEVELOPMENTS
• TABLE 222 BEBIG MEDICAL GMBH: PRODUCTS OFFERED
• TABLE 223 BEBIG MEDICAL GMBH: KEY DEVELOPMENTS
• TABLE 224 THERAGENICS CORPORATION: PRODUCTS OFFERED
• TABLE 225 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
• TABLE 226 SIEMENS HEALTHINEERS AG: KEY DEVELOPMENTS
• TABLE 227 ECKERT & ZIEGLER: PRODUCT OFFERED
• TABLE 228 ECKERT & ZIEGLER: KEY DEVELOPMENTS
• TABLE 229 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
• TABLE 230 GE HEALTHCARE: PRODUCTS OFFERED
• TABLE 231 GE HEALTHCARE: KEY DEVELOPMENTS
• TABLE 232 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
• TABLE 233 MERIT MEDICAL SYSTEMS: KEY DEVELOPMENTS
• TABLE 234 BEST MEDICAL INTERNATIONAL, INC.: PRODUCTS OFFERED
• TABLE 235 BEST MEDICAL INTERNATIONAL, INC.: KEY DEVELOPMENTS
• TABLE 236 ISOAID, LLC: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL BRACHYTHERAPY MARKET: STRUCTURE
• FIGURE 2 GLOBAL BRACHYTHERAPY MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
• FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
• FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BRACHYTHERAPY MARKET
• FIGURE 6 GLOBAL BRACHYTHERAPY MARKET, PRODUCT SEGMENT, 2023 &
• FIGURE 7 GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
• FIGURE 8 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY PRODUCT,
• FIGURE 9 GLOBAL BRACHYTHERAPY MARKET, TYPE SEGMENT, 2023 &
• FIGURE 10 GLOBAL BRACHYTHERAPY MARKET, BY TYPE, 2023 & 2032 (USD BILLION)
• FIGURE 11 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY TYPE,
• FIGURE 12 GLOBAL BRACHYTHERAPY MARKET, TECHNIQUE SEGMENT, 2023 &
• FIGURE 13 GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2023 & 2032 (USD BILLION)
• FIGURE 14 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY TECHNIQUE,
• FIGURE 15 GLOBAL BRACHYTHERAPY MARKET, INDICATION SEGMENT, 2023 &
• FIGURE 16 GLOBAL BRACHYTHERAPY MARKET, BY INDICATION, 2023 & 2032 (USD BILLION)
• FIGURE 17 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY INDICATION,
• FIGURE 18 GLOBAL BRACHYTHERAPY MARKET, END USER SEGMENT, 2023 &
• FIGURE 19 GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2023 & 2032 (USD BILLION)
• FIGURE 20 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY END USER,
• FIGURE 21 GLOBAL BRACHYTHERAPY MARKET, BY REGION, 2023 & 2032 (USD BILLION)
• FIGURE 22 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY REGION,
• FIGURE 23 NORTH AMERICA MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
• FIGURE 24 NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
• FIGURE 25 NORTH AMERICA BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY,
• FIGURE 26 EUROPE MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
• FIGURE 27 EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
• FIGURE 28 EUROPE BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY,
• FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
• FIGURE 30 ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
• FIGURE 31 ASIA-PACIFIC BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY,
• FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
• FIGURE 33 REST OF THE WORLD: BRACHYTHERAPY MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
• FIGURE 34 REST OF THE WORLD: BRACHYTHERAPY MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 35 GLOBAL BRACHYTHERAPY MARKET PLAYERS: COMPETITIVE ANALYSIS,
• FIGURE 36 COMPETITOR DASHBOARD: GLOBAL BRACHYTHERAPY MARKET
• FIGURE 37 ELEKTA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 38 ELEKTA: SWOT ANALYSIS
• FIGURE 39 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 40 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
• FIGURE 41 ECKERT & ZIEGLER: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 42 ECKERT & ZIEGLER: SWOT ANALYSIS
• FIGURE 43 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 44 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
• FIGURE 45 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 46 GE HEALTHCARE: SWOT ANALYSIS
• FIGURE 47 MERIT MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT

Brachytherapy Market Research Report Information, By Product (Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others), By Type (High Dose-Rate (HDR) Brachytherapy, Low Dose-Rate (LDR) Brachytherapy), By Technique (Interstitial Brachytherapy, Intracavitary Brachytherapy), By Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry Forecast Till 2032

Overview of the Market

In 2023, the brachytherapy market was estimated to be worth USD 0.98 billion. With a compound annual growth rate (CAGR) of 6.84% from 2024 to 2032, the sector is expected to increase from USD 1.07 billion in 2024 to USD 1.94 billion by 2032. The global rise in cancer cases and the number of new product launches are fueling the market's expansion.

By giving cancer patients more treatment alternatives, the introduction of brachytherapy services is greatly accelerating the growth of the brachytherapy market. More patients looking for efficient substitutes for conventional radiation therapy are drawn to healthcare facilities as they broaden their offers to include this focused, minimally invasive technique. Brachytherapy is improving patient outcomes and satisfaction by directly delivering focused radiation doses to malignancies while protecting healthy tissue.

Furthermore, patients' and healthcare providers' acceptance is being aided by shorter treatment durations and fewer adverse effects. An important development in the treatment of cervical and esophageal cancers was the introduction of brachytherapy services by Karnataka Medical College and Research Institute (India) in September 2024.

Perspectives on Market Segments

Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others are the product-based divisions of the Brachytherapy market.

The market has been divided into two segments based on type: low dose-rate (LDR) brachytherapy and high dose-rate (HDR) brachytherapy.

The brachytherapy market has been divided into two segments based on technique: intracavity brachytherapy and interstitial brachytherapy.

The market has been divided into several segments based on indications, including skin cancer, breast cancer, prostate cancer, and cervical cancer.

The market for brachytherapy has been divided into three segments based on end users: cancer treatment centers, hospitals and specialty clinics, and others.

Regional Perspectives

The market for brachytherapy has been divided into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In 2023, North America held the biggest market share. Nonetheless, over the course of the forecast period, Asia-Pacific is anticipated to develop at the highest CAGR of 7.98%.

The market for brachytherapy is expanding quickly in North America, which is indicative of major developments in cancer treatment strategies. The need for efficient treatments has increased as cancer rates grow, especially for localized types including cervical, breast, and prostate cancers.

The market for brachytherapy in Asia-Pacific is expanding rapidly due to a number of interconnected factors. The need for efficient treatment alternatives has increased due to a notable rise in the incidence of cancer, especially breast, prostate, and cervical malignancies.

In addition, the rest of the world is further separated into South America, Africa, and the Middle East. The region's economic growth has raised healthcare expenditures, improving access to cutting-edge cancer treatment alternatives.

Key Players

Siemens Healthineers AG, Elekta, BEBIG Medical Gmbh, Becton, Dickinson and Company (US), GE Healthcare (US), Merit Medical Systems (US), Best Medical International, Inc. (US), IsoAid, LLC (US), Theragenics Corporation, Eckert & Ziegler, and others are major competitors in the brachytherapy market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research Data Flow:
  • 3.5.2 Primary Research: Number of Interviews conducted
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 Microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Introduction of Brachytherapy Services
  • 4.2.2 Increasing incidences of cancer across the globe
  • 4.2.3 Increasing number of product launch
  • 4.2.4 Growing awareness among healthcare providers and patients about the benefits of brachytherapy
• 4.3 RESTRAINTS
  • 4.3.1 High Cost of Brachytherapy Treatment
  • 4.3.2 Competition From Alternative cancer treatment modalities
• 4.4 OPPORTUNITY
  • 4.4.1 Expansion of brachytherapy applications
  • 4.4.2 Technological Advancements associated with Brachytherapy
  • 4.4.3 Growing Expansion of Brachytherapy Manufacturing Facility and product portfolio

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 Threat of New Entrants
  • 5.1.2 Bargaining Power Of Suppliers
  • 5.1.3 Threat of Substitutes
  • 5.1.4 Bargaining Power of Buyers
  • 5.1.5 Intensity of Rivalry
• 5.2 IMPACT OF COVID-19 ON GLOBAL BRACHYTHERAPY MARKET

6 GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT

• 6.1 OVERVIEW
• 6.2 AFTERLOADERS & APPLICATORS
• 6.3 RADIOACTIVE SEEDS
• 6.4 ELECTRONIC BRACHYTHERAPY
• 6.5 IMAGING SYSTEMS
• 6.6 OTHERS

7 GLOBAL BRACHYTHERAPY MARKET, BY TYPE

• 7.1 OVERVIEW
• 7.2 HIGH DOSE-RATE (HDR) BRACHYTHERAPY
• 7.3 LOW DOSE-RATE (LDR) BRACHYTHERAPY

8 GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE

• 8.1 OVERVIEW
• 8.2 INTERSTITIAL BRACHYTHERAPY
• 8.3 INTRACAVITARY BRACHYTHERAPY

9 GLOBAL BRACHYTHERAPY MARKET, BY INDICATION

• 9.1 OVERVIEW
• 9.2 PROSTATE CANCER
• 9.3 BREAST CANCER
• 9.4 CERVICAL CANCER
• 9.5 SKIN CANCER
• 9.6 OTHERS

10 GLOBAL BRACHYTHERAPY MARKET, BY END USER

• 10.1 OVERVIEW
• 10.2 HOSPITALS AND SPECIALTY CLINICS
• 10.3 CANCER TREATMENT CENTERS
• 10.4 OTHERS

11 GLOBAL BRACHYTHERAPY MARKET, BY REGION

• 11.1 OVERVIEW
• 11.2 NORTH AMERICA
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 EUROPE
  • 11.3.1 Germany
  • 11.3.2 France
  • 11.3.3 UK
  • 11.3.4 Italy
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 ASIA-PACIFIC
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 South Korea
  • 11.4.5 Australia
  • 11.4.6 Rest of Asia-Pacific
• 11.5 REST OF THE WORLD
  • 11.5.1 Middle East
    • 11.5.1.1 SAUDI ARABIA
    • 11.5.1.2 UNITED ARAB EMIRATES
    • 11.5.1.3 OMAN
    • 11.5.1.4 QATAR
    • 11.5.1.5 TURKEY
    • 11.5.1.6 KUWAIT
    • 11.5.1.7 BAHRAIN
    • 11.5.1.8 REST OF MIDDLE EAST
  • 11.5.2 Africa
    • 11.5.2.1 SOUTH AFRICA
    • 11.5.2.2 MOROCCO
    • 11.5.2.3 REST OF AFRICA
  • 11.5.3 South America
    • 11.5.3.1 BRAZIL
    • 11.5.3.2 ARGENTINA
    • 11.5.3.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 MARKET SHARE ANALYSIS,
• 12.3 COMPETITOR DASHBOARD
• 12.4 PUBLIC PLAYERS STOCK SUMMARY
• 12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 12.6.1 PRODUCT LAUNCH
  • 12.6.2 PRODUCT APPROVAL
  • 12.6.3 ACQUISITION

13 COMPANY PROFILES

• 13.1 ELEKTA
  • 13.1.1 COMPANY OVERVIEW
  • 13.1.2 FINANCIAL OVERVIEW
  • 13.1.3 PRODUCT OFFERED
  • 13.1.4 KEY DEVELOPMENTS
  • 13.1.5 SWOT ANALYSIS
  • 13.1.6 KEY STRATEGIES
• 13.2 BEBIG MEDICAL GMBH
  • 13.2.1 OMPANY OVERVIEW
  • 13.2.2 FINANCIAL OVERVIEW
  • 13.2.3 PRODUCTS OFFERED
  • 13.2.4 KEY DEVELOPMENTS
  • 13.2.5 KEY STRATEGIES
• 13.3 THERAGENICS CORPORATION
  • 13.3.1 COMPANY OVERVIEW
  • 13.3.2 FINANCIAL OVERVIEW
  • 13.3.3 PRODUCTS OFFERED
  • 13.3.4 KEY DEVELOPMENTS
  • 13.3.5 KEY STRATEGIES
• 13.4 SIEMENS HEALTHINEERS AG
  • 13.4.1 COMPANY OVERVIEW
  • 13.4.2 FINANCIAL OVERVIEW
  • 13.4.3 PRODUCTS OFFERED
  • 13.4.4 KEY DEVELOPMENTS
  • 13.4.5 SWOT ANALYSIS
  • 13.4.6 KEY STRATEGIES
• 13.5 ECKERT & ZIEGLER
  • 13.5.1 COMPANY OVERVIEW
  • 13.5.2 FINANCIAL OVERVIEW
  • 13.5.3 PRODUCTS OFFERED
  • 13.5.4 KEY DEVELOPMENTS
  • 13.5.5 SWOT ANALYSIS
  • 13.5.6 KEY STRATEGIES
• 13.6 BECTON, DICKINSON AND COMPANY
  • 13.6.1 COMPANY OVERVIEw
  • 13.6.2 FINANCIAL OVERVIEW
  • 13.6.3 PRODUCTS OFFERED
  • 13.6.4 KEY DEVELOPMENTS
  • 13.6.5 SWOT ANALYSIS
  • 13.6.6 KEY STRATEGIES
• 13.7 GE HEALTHCARE
  • 13.7.1 COMPANY OVERVIEW
  • 13.7.2 FINANCIAL OVERVIEW
  • 13.7.3 PRODUCTS OFFERED
  • 13.7.4 KEY DEVELOPMENTS
  • 13.7.5 SWOT ANALYSIS
  • 13.7.6 KEY STRATEGIES
• 13.8 MERIT MEDICAL SYSTEMS
  • 13.8.1 COMPANY OVERVIEW
  • 13.8.2 FINANCIAL OVERVIEW
  • 13.8.3 PRODUCTS OFFERED
  • 13.8.4 KEY DEVELOPMENTS
  • 13.8.5 KEY STRATEGIES
• 13.9 BEST MEDICAL INTERNATIONAL, INC.
  • 13.9.1 COMPANY OVERVIEW
  • 13.9.2 FINANCIAL OVERVIEW
  • 13.9.3 PRODUCTS OFFERED
  • 13.9.4 KEY DEVELOPMENTS
  • 13.9.5 KEY STRATEGIES
• 13.10 ISOAID, LLC
  • 13.10.1 COMPANY OVERVIEW
  • 13.10.2 FINANCIAL OVERVIEW
  • 13.10.3 PRODUCTS OFFERED
  • 13.10.4 KEY DEVELOPMENTS
  • 13.10.5 KEY STRATEGIES

14 DATA CITATIONS